BMS vs. Janssen: Which Company Will Dominate the Multiple Myeloma Treatment Market This Decade? In the competitive arena of multiple myeloma treatment, Bristol-Myers Squibb (BMS) and Janssen Pharmaceutical are two leading pharmaceutical giants vying for dominance. As the multiple myeloma market continues to evolve, the performance of their respective pipelines and treatments will...